- Home
- KALA vs MKZR Comparison
KALA vs MKZR Comparison
Compare KALA & MKZR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KALA
- MKZR
- Stock Information
- Founded
- KALA 2009
- MKZR 2012
- Country
- KALA United States
- MKZR United States
- Employees
- KALA N/A
- MKZR N/A
- Industry
- KALA Biotechnology: Pharmaceutical Preparations
- MKZR
- Sector
- KALA Health Care
- MKZR
- Exchange
- KALA Nasdaq
- MKZR Nasdaq
- Market Cap
- KALA 27.3M
- MKZR 31.4M
- IPO Year
- KALA 2017
- MKZR N/A
- Fundamental
- Price
- KALA $6.64
- MKZR $1.93
- Analyst Decision
- KALA Strong Buy
- MKZR
- Analyst Count
- KALA 2
- MKZR 0
- Target Price
- KALA $15.00
- MKZR N/A
- AVG Volume (30 Days)
- KALA 108.1K
- MKZR 197.0K
- Earning Date
- KALA 03-28-2025
- MKZR 01-01-0001
- Dividend Yield
- KALA N/A
- MKZR 15.54%
- EPS Growth
- KALA N/A
- MKZR N/A
- EPS
- KALA N/A
- MKZR N/A
- Revenue
- KALA N/A
- MKZR $23,087,751.00
- Revenue This Year
- KALA N/A
- MKZR N/A
- Revenue Next Year
- KALA N/A
- MKZR N/A
- P/E Ratio
- KALA N/A
- MKZR N/A
- Revenue Growth
- KALA N/A
- MKZR 57.39
- 52 Week Low
- KALA $4.21
- MKZR $1.05
- 52 Week High
- KALA $11.20
- MKZR $5.50
- Technical
- Relative Strength Index (RSI)
- KALA 39.29
- MKZR N/A
- Support Level
- KALA $6.50
- MKZR N/A
- Resistance Level
- KALA $8.65
- MKZR N/A
- Average True Range (ATR)
- KALA 0.90
- MKZR 0.00
- MACD
- KALA -0.43
- MKZR 0.00
- Stochastic Oscillator
- KALA 2.98
- MKZR 0.00
About KALA KALA BIO Inc.
Kala Bio Inc is a biopharmaceutical company. The company is a clinical-stage biopharmaceutical company dedicated to researching, developing, and commercializing therapies for rare and severe eye diseases. KALA'smain product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.
About MKZR MacKenzie Realty Capital Inc.
Mackenzie Realty Capital Inc is a company which is a Real estate investment trust (REIT). The company has one reportable segment, income-producing real estate properties which consists of activities related to investing in real estate.